HomeScienceTonsil Organoids Reveal Epstein–Barr I
SCIENCE

Tonsil Organoids Reveal Epstein–Barr Infection States

A peer-reviewed study in PNAS uses tonsil organoids to identify germinal center B cell states during primary Epstein–Barr virus infection.

WHAT YOU NEED TO KNOW
  • PNAS published the peer-reviewed research on August 13, 2026.
  • The study applies a tonsil organoid model to identify germinal center B cell states during primary Epstein–Barr virus infection.
  • The work is indexed under DOI 10.1073/pnas.2603586123.

Researchers used a tonsil organoid model to identify distinct germinal center B cell states that emerge during primary Epstein–Barr virus infection, according to peer-reviewed findings released by PNAS.

The study tracks the cellular dynamics of Epstein–Barr virus within laboratory-grown tonsil tissue during the initial infection phase. By cultivating tonsil organoids, the experimental system models the biological environment where primary infection takes place, allowing direct observation of germinal center B cells as they respond to the pathogen.

PNAS issued the research on August 13, 2026, at 07:00 UTC. The investigation details the specific transitional states of infected B cells within the germinal center microenvironment, establishing an experimental record of early host-pathogen interactions in structured lymphoid tissue.

The findings document the viral infection process through the organoid system under digital object identifier 10.1073/pnas.2603586123. The peer-reviewed dataset maps how germinal center B cells behave from the onset of primary Epstein–Barr virus exposure within the modeled tonsil architecture.

Xentir Media
Xentir Media NewsroomSource-backed AI and technology coverage, drafted by Xentir's automated editorial system under fixed human-set rules. See our editorial policy and AI usage policy.
J
Jomon · Founder & EditorFounder and editor of Xentir Media. Sets the editorial rules the newsroom system runs under, and is accountable for its corrections. About Jomon · [email protected]
The Xentir Brief
The developments worth knowing — one useful email.
Get the Brief →